Strategic Communications and Marketing News Bureau

Fred A. Kummerow, successful crusader against trans fats, dies at 102

CHAMPAIGN, Ill. — Fred A. Kummerow, a pioneer in the study of dietary contributors to heart disease who led a decades-long crusade to remove trans fats from the food supply, died Wednesday, May 31, at his home in Urbana, Illinois. He was 102.

Kummerow was a professor of comparative biosciences who maintained a laboratory at the University of Illinois at Urbana-Champaign until he was 101, often dipping into his own funds to pay the scientists who worked with him.

Throughout his career, which began in the 1940s, Kummerow challenged orthodoxy in science. His dogged determination to bring to light findings that contradicted popular notions about diet and health sometimes cost him friends and research funds. He argued, for example, that dietary sources of cholesterol like meat and eggs had no influence on heart disease unless they were prepared in a manner that oxidized the cholesterol.

Kummerow’s early work on heart disease led him to realize, decades before anyone else, that artificial trans fats in food were clogging arteries and interfering with blood flow dynamics. His earliest research on trans fats dates to 1957.

Kummerow’s efforts to remove trans fats from foods began in 1968, when he urged the American Heart Association to ask the Institute of Shortening and Edible Oils to have its members reduce the amount of trans fatty acids in shortenings and margarines, replacing them with essential fatty acids such as linoleic acid. The industry reluctantly agreed. That change coincided with a steady decrease in coronary heart disease mortality after 1968, a decline Kummerow saw as additional evidence that trans fats endanger the heart. (Heart disease rates had been climbing before that.)

In 2009, when he was 94, Kummerow filed a citizen’s petition with the U.S. Food and Drug Administration requesting that it “ban partially hydrogenated fat from the American diet.” His 3,000-word petition documented the science linking trans fats in food to inflammation, an increase of LDL cholesterol, a buildup of plaque and an increased risk of blood clots in the coronary arteries.

“Everybody should read my petition because it will scare the hell out of them,” he said at the time.

When the FDA failed to respond to his petition for four years – the law requires a response within 180 days – Kummerow, then 98, filed a lawsuit to force the agency to make a determination on his petition. Three months later, the FDA announced a “tentative determination” that trans fatty acids “are not generally recognized as safe for any use in food.”

“Professor Kummerow was a maverick and a trailblazer, and his vision and persistence are, to this day, transforming the American diet,” said Urbana-Champaign Chancellor Robert Jones. “We are lucky that he chose to use his intellectual gifts in this way, and that, in spite of decades of opposition and hardship, he never gave up.”

Kummerow attended the University of Wisconsin, Madison, earning a B.S. in chemistry in 1939 and a Ph.D. in biochemistry in 1943. He worked as a nutritionist at Clemson University and a professor of chemistry at Kansas State University before joining the U. of I. faculty in 1950. He began his career at Illinois in the department of food science and human nutrition, from which he retired in 1985. Unwilling to suspend his research, he joined the department of veterinary biosciences (now comparative biosciences) in 2001, a position he held until his death.

Kummerow is survived by his three children, Max, Jean and Kay Kummerow; three grandchildren, Elizabeth Loban, Robert Loban and Patrick Watson; and one great-grandson, Asher Watson. The family is planning a memorial service for late summer.

Watch a video about his life and work.          



This article was imported from a previous version of the News Bureau website. Please email news@illinois.edu to report missing photos and/or photo credits.

Read Next

Announcements

Wright selected as U. of I.’s vice chancellor for advancement

Dale Wright, currently the interim vice chancellor for advancement at the University of Illinois Urbana-Champaign, will become the permanent vice chancellor for advancement and senior vice president of the University of Illinois Foundation, pending approval by the University of Illinois Board of Trustees. Until approved by the Board of Trustees, his title will be vice […]

Health and Medicine Sara Gerke, the Richard W. & Marie L. Corman Scholar at the University of Illinois Urbana-Champaign and expert in legal issues surrounding cutting-edge medical developments.

New paper urges caution as FDA plans to phase out animal testing in drug development

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals, but such a novel approach needs to be implemented judiciously and with caution.

Humanities Diptych image with the book cover of "Indifferent Cities" and a photo of Angel Garcia.

Illinois English professor explores his lost family history in new poetry collection

CHAMPAIGN, Ill. — Poet Ángel García examines his disrupted family lineage in his new collection of poetry, seeking answers about where he came from and trying to fill the many gaps in his family’s story. “Indifferent Cities” is the second book by García, a University of Illinois Urbana-Champaign English professor. The book was the winner […]

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010